A, B., O, G., N, B., D, B., & W, V. D. (2023). ASO Author Reflections: Which HIPEC Regimens Should be Used in Patients with Epithelial Ovarian Cancer? In the Clinic and in Randomized Trials. Annals of surgical oncology, 30(13), 8166. https://doi.org/10.1245/s10434-023-13981-8
Chicago Style (17th ed.) CitationA, Bhatt, Glehen O, Bakrin N, Brennan D, and Van Driel W. "ASO Author Reflections: Which HIPEC Regimens Should Be Used in Patients with Epithelial Ovarian Cancer? In the Clinic and in Randomized Trials." Annals of Surgical Oncology 30, no. 13 (2023): 8166. https://doi.org/10.1245/s10434-023-13981-8.
MLA (9th ed.) CitationA, Bhatt, et al. "ASO Author Reflections: Which HIPEC Regimens Should Be Used in Patients with Epithelial Ovarian Cancer? In the Clinic and in Randomized Trials." Annals of Surgical Oncology, vol. 30, no. 13, 2023, p. 8166, https://doi.org/10.1245/s10434-023-13981-8.